Skip to main content

"We've detected that you're visiting from {0}. Would you like to switch languages for tailored content?"

Solventum completes acquisition of Acera Surgical.

Welcome to the Acera team and their innovative Restrata® technology. Together, we are advancing the future of wound care and expanding access for surgeons and their patients. Read more here.

3M's healthcare business is now a standalone company: Solventum

Rooted in a history of diverse product offerings spanning the industry — from Solventum™ V.A.C.® Therapy to Solventum™ Filtek™ Dental Restoratives — we’re ushering in a new era of care

Male patient sitting in a chair with an IV attached to his arm. A smiling nurse kneels beside him checking on the patient's IV.

News & Stories

Solventum to Report Second Quarter Fiscal 2026 Earnings on August 5, 2026

Solventum will release its second quarter fiscal 2026 financial results on Wednesday, August 5, 2026, after the U.S. financial markets close. Following the release, Solventum management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.

Solventum logo in full color.
A medical doctor with stethoscope, a dentist with loupes, an engineer/water professional and software coder.

Our company

Learn more about our new company with a proud history of creating breakthrough solutions to improve healthcare for all.